Evidence map›Paper›PMID 35268683›Full record

ArticleMolecules (Basel, Switzerland)2022

Inhibitory Effect of

Xuejiao Leng, Hongfei Kan, Qinhang Wu, Cunyu Li, Yunfeng Zheng, Guoping Peng

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
4.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Recent developments inFrontiers in pharmacology · 2023
    Review
  9. Lignans fromEvidence-based complementary and alternative medicine : eCAM · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Xuejiao LengCollege of Pharmacy, Nanjing University of Chinese Medicine, 138 Xianlin Avenue, Qixia District, Nanjing 210023, China.
Hongfei KanCollege of Pharmacy, Nanjing University of Chinese Medicine, 138 Xianlin Avenue, Qixia District, Nanjing 210023, China.
Qinhang WuCollege of Pharmacy, Nanjing University of Chinese Medicine, 138 Xianlin Avenue, Qixia District, Nanjing 210023, China.ORCID 0000-0001-6718-8501
Cunyu LiCollege of Pharmacy, Nanjing University of Chinese Medicine, 138 Xianlin Avenue, Qixia District, Nanjing 210023, China.
Yunfeng ZhengCollege of Pharmacy, Nanjing University of Chinese Medicine, 138 Xianlin Avenue, Qixia District, Nanjing 210023, China.
Guoping PengCollege of Pharmacy, Nanjing University of Chinese Medicine, 138 Xianlin Avenue, Qixia District, Nanjing 210023, China.
Nanjing University of Chinese Medicine · CN

Funding

Jiangsu Zhengyang Pharmaceutical Co., Ltd No. ZY002the National Natural Science Foundation of China (NSFC) No. 82104451
6 · The paper itself

Abstract

The effective treatment of cervical intraepithelial neoplasia (CIN) can prevent cervical cancer.

Indexed as

Cell ProliferationPlant ExtractsSalvia miltiorrhizaUterine Cervical NeoplasmsAntineoplastic Agents, PhytogenicApoptosisBenzofuransCell Line, TumorDepsidesFemaleHumansUterine Cervical DysplasiaAntineoplastic Agents, PhytogenicBenzofuransDepsidesPlant Extractssalvianolic acid Bcervical intraepithelial neoplasiaG2/M phase arrestoxysophoridinesalvianolic acid Asynergistic effect

Identifiers

PMID35268683
PMCPMC8911905
OpenAlexW4214665414

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.